Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anupong Tangpeerachaikul

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Cancer Therapeutics|April 29, 2025
Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant MutationsAnupong Tangpeerachaikul, Scot Mente, Joe Magrino, et al.
Journal of the American Chemical Society|December 20, 2011
Diels-Alder cycloaddition for fluorophore targeting to specific proteins inside living cellsDaniel S Liu, Anupong Tangpeerachaikul, Ramajeyam Selvaraj, et al.
Cell Reports|April 7, 2016
Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative PhosphoproteomicsZachary C Poss, Christopher C Ebmeier, Aaron T Odell, et al.
Cancer Discovery|December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance MutationsAlexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Nature|September 30, 2015
Mediator kinase inhibition further activates super-enhancer-associated genes in AMLHenry E Pelish, Brian B Liau, Ioana I Nitulescu, et al.
Cancer Discovery|September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound MutationsJessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|April 29, 2025
Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant MutationsAnupong Tangpeerachaikul, Scot Mente, Joe Magrino, et al.
Journal of the American Chemical Society|December 20, 2011
Diels-Alder cycloaddition for fluorophore targeting to specific proteins inside living cellsDaniel S Liu, Anupong Tangpeerachaikul, Ramajeyam Selvaraj, et al.
Cell Reports|April 7, 2016
Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative PhosphoproteomicsZachary C Poss, Christopher C Ebmeier, Aaron T Odell, et al.
Cancer Discovery|December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance MutationsAlexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Nature|September 30, 2015
Mediator kinase inhibition further activates super-enhancer-associated genes in AMLHenry E Pelish, Brian B Liau, Ioana I Nitulescu, et al.
Cancer Discovery|September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound MutationsJessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Pageof 1